XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 1 filers reported holding XENON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,096,535 | -77.8% | 178,470 | -75.0% | 0.03% | -76.9% |
| Q2 2023 | $27,430,403 | -22.3% | 712,478 | -27.8% | 0.12% | -32.8% |
| Q1 2023 | $35,295,919 | -24.9% | 986,195 | -17.2% | 0.17% | -39.4% |
| Q4 2022 | $46,986,286 | -28.8% | 1,191,638 | -34.9% | 0.29% | -32.0% |
| Q3 2022 | $66,032,000 | +18.7% | 1,829,152 | 0.0% | 0.42% | +25.6% |
| Q2 2022 | $55,643,000 | +100.1% | 1,829,152 | +101.1% | 0.34% | +131.7% |
| Q1 2022 | $27,807,000 | – | 909,628 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |